These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11965921)

  • 1. FDA approves once-daily efavirenz formulation, revised labeling.
    AIDS Treat News; 2002 Mar; (378):7. PubMed ID: 11965921
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA approves Sustiva (efavirenz) capsules, first once-daily anti-HIV drug. Food and Drug Administration.
    Res Initiat Treat Action; 1998 Oct; 4(6):13-4. PubMed ID: 11365915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efavirenz (Sustiva) on fast-track for FDA accelerated approval. Food and Drug Administration.
    Baker R
    BETA; 1998 Jul; ():9. PubMed ID: 11365571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA approves efavirenz. Food and Drug Administration.
    Highleyman L
    BETA; 1998 Oct; ():3. PubMed ID: 11365987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA notifications. Changes approved for Sustiva.
    AIDS Alert; 2002 Apr; 17(4):51. PubMed ID: 12030202
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA notifications. FDA tentatively approves efavirenz cross-scored tablets.
    AIDS Alert; 2010 Apr; 25(4):45. PubMed ID: 20560191
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA notifications. FDA tentatively approves generic efavirenz.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17577959
    [No Abstract]   [Full Text] [Related]  

  • 8. Once-daily nonnucleoside reverse-transcriptase inhibitor approved.
    Am J Health Syst Pharm; 1998 Dec; 55(23):2458. PubMed ID: 9853628
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA notifications. FDA approves efavirenz insert revisions.
    AIDS Alert; 2010 Jul; 25(7):83-4. PubMed ID: 20806792
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustiva granted full FDA approval.
    AIDS Read; 2000 Mar; 10(3):147. PubMed ID: 10798886
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. FDA approves label change for nevirapine.
    AIDS Alert; 2008 Aug; 23(8):91-2. PubMed ID: 18724490
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. Generic efavirenz capsules tentatively approved by FDA.
    AIDS Alert; 2009 Dec; 24(12):143. PubMed ID: 20063479
    [No Abstract]   [Full Text] [Related]  

  • 13. Efavirenz approved in the U.S.
    TreatmentUpdate; 1998 Oct; 10(8):3-4. PubMed ID: 11365876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA notifications. FDA approves generic combination of efavirenz, lamivudine & tenofovir.
    AIDS Alert; 2009 Nov; 24(11):130. PubMed ID: 19960612
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. Generic stavudine and efavirenz are tentatively approved by FDA.
    AIDS Alert; 2008 Apr; 23(4):46. PubMed ID: 19253455
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protease inhibitor sparing standard. Once daily efavirenz continues to be effective].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():18-20. PubMed ID: 15373038
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent FDA approvals and changes.
    AIDS Patient Care STDS; 2010 Jun; 24(6):396-7. PubMed ID: 20572321
    [No Abstract]   [Full Text] [Related]  

  • 18. Once-daily drug for persons with HIV.
    Am Fam Physician; 1998 Dec; 58(9):2174-5. PubMed ID: 9861886
    [No Abstract]   [Full Text] [Related]  

  • 19. Efavirenz switches may be beneficial.
    AIDS Patient Care STDS; 2001 Sep; 15(9):496. PubMed ID: 11603362
    [No Abstract]   [Full Text] [Related]  

  • 20. Can efavirenz be taken in the morning?
    Skeie L; Maeland A
    Scand J Infect Dis; 2006; 38(11-12):1089-91. PubMed ID: 17148083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.